BioPorto Diagnostics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ProNephro NGAL Test for Early Detection of Acute Kidney Injury in Adult ICU Patients (ALPACA) (NCT07751913) | BioPorto Diagnostics | 2026-08-01 |
| Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults (NCT06652100) | BioPorto Diagnostics | 2024-10-28 |
| The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population (NCT03057457) | BioPorto Diagnostics | 2017-03-01 |
| NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care (NCT02121470) | BioPorto Diagnostics | 2014-02-01 |
Track BioPorto Diagnostics automatically
Every clearance here is in the API, with alerts when new ones post.